There have been nearly 30 years of disease modifying trials for PD, but little success. Prof. Tanya Simuni breaks down clinical trial design for a heterogenous disease like PD and discusses the future goals and importance of a biological definition.
Read MoreThe field of genetics often moves quickly, making it a challenge to stay informed. Dr. Gerard Saranza breaks down the current landscape, new discoveries and technologies, and what changes we can expect in the upcoming years.
Read MoreDue to genetic advancements, the pediatric movement disorder field is ever growing. Dr. Shekeeb Mohammad breaks down the current landscape of the field and how adult neurologists can advance their learning.
Read MoreRehabilitation for movement disorders, like PD, has become increasingly prevalent for patient care. Prof. Alice Nieuwboer discusses how technology has shaped the field, how neurologists can support patient exercise, and what future updates she looks forward to.
Read More
The last full day of the #mdscongress was full of exciting sessions and events. Dr. Laura Silveira-Moriyama shares her excitement about the keynote speaker, updates on disease modifying clinical trials, and of course, the crowd pleasing MDS Video Challenge.
Read MoreDr. Huw Morris discusses the session highlights from #mdscongress day three, which included a plenary session on protein aggregation clearance, movement disorder grand rounds, and several exciting oral platforms.
Read MoreProf. Francesca Morgante breaks down the second day of the #mdscongress which included the presidential lectures, junior awardees, and several enlightening teaching sessions.
Read MoreAn eventful first day of the 2025 #mdscongress has come to a close. Listen here as Dr. Davide Martino reviews the events and interesting scientific sessions for those near and far. Don’t miss out!
Read MoreDr. Eduardo de Pablo-Fernández interviews one of the 2025 Junior Awardees, Dr. Lydia Chougar about her work combining neuroimaging with transcriptomics and PET maps to elucidate the biological underpinnings of structural abnormalities in multiple system atrophy.
Read More